Basaglar and Triamcinolone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Basaglar (insulin glargine) and Triamcinolone (triamcinolone). Common drug interactions include chronic kidney disease among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Basaglar and Triamcinolone. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Basaglar?

Basaglar has active ingredients of insulin glargine. eHealthMe is studying from 19,807 Basaglar users. Check the latest studies of Basaglar.

What is Triamcinolone?

Triamcinolone has active ingredients of triamcinolone. eHealthMe is studying from 25,577 Triamcinolone users. Check the latest studies of Triamcinolone.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 27, 2026

35 people who take Basaglar and Triamcinolone together, and have interactions are studied.

Basaglar and Triamcinolone drug interactions.

What are the common drug interactions of Basaglar and Triamcinolone, by gender? *:

female:

  1. Chronic kidney disease
  2. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  3. Drug ineffective
  4. Fungal infection
  5. Acne (skin problems that cause pimples)
  6. Anxiety
  7. Back pain
  8. Breast cancer metastatic
  9. Constipation
  10. Dyspnoea (difficult or laboured respiration)

male:

  1. Fatigue (feeling of tiredness)
  2. Arthralgia (joint pain)
  3. General physical health deterioration (weak health status)
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Impaired healing
  6. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  7. Nightmare (unpleasant dream)
  8. Osteopenia (a condition where bone mineral density is lower than normal)
  9. Pain
  10. Rash erythematous (redness of the skin)

What are the common drug interactions of Basaglar and Triamcinolone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Peripheral swelling

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Ankle fracture
  3. Anxiety
  4. Arthralgia (joint pain)
  5. Bone pain
  6. Crepitations (noises are produced by the rubbing of parts one against the other)
  7. Emotional distress
  8. Fatigue (feeling of tiredness)
  9. Gait disturbance
  10. General physical health deterioration (weak health status)

50-59:

  1. Breast cancer metastatic
  2. Chronic kidney disease
  3. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Anxiety
  6. Chronic respiratory failure
  7. Emotional distress
  8. Fatigue (feeling of tiredness)
  9. Gait disturbance
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

60+:

  1. Chronic kidney disease
  2. Drug ineffective
  3. Back pain
  4. Balance disorder
  5. Blood glucose decreased
  6. Blood glucose increased
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Cholecystitis acute (rapid infection of gallbladder)
  9. Cholecystitis infective (infection of gallbladder capable to infect other organs)
  10. Confusional state

What are the existing conditions these people have? *

  1. Pain: 6 people, 17.14%
  2. High Blood Cholesterol: 5 people, 14.29%
  3. Rashes (redness): 4 people, 11.43%
  4. Diabetes: 4 people, 11.43%
  5. Wheezing (a high-pitched whistling sound made while you breath): 3 people, 8.57%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 8.57%
  7. Cardiac Failure Congestive: 3 people, 8.57%
  8. Gout (uric acid crystals building up in the body): 3 people, 8.57%
  9. High Blood Pressure: 3 people, 8.57%
  10. Type 2 Diabetes: 3 people, 8.57%

* Approximation only. Some reports may have incomplete information.

Do you take Basaglar and Triamcinolone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Basaglar and Triamcinolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Basaglar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Triamcinolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Basaglar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Triamcinolone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on insulin glargine and triamcinolone (the active ingredients of Basaglar and Triamcinolone, respectively), and Basaglar and Triamcinolone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: